Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

BACKGROUND: Neuromyelitis optica (NMO) is a severe autoimmune inflammatory disorder associated with considerable relapse-related disability. Immunosuppression is the mainstay of treatment but many patients do not tolerate first-line immunosuppressive agents, or experience ongoing relapses. OBJECTIV...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J
Materialtyp:	Journal article
Språk:	English
Publicerad:	2013

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies av Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J

Publicerad 2013

Journal article

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies av Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J

Liknande verk